Your browser doesn't support javascript.
loading
Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial.
Lorenzatti, Alberto J; Eliaschewitz, Freddy G; Chen, Yundai; Fialkow, Jonathan; Lu, Juming; Baass, Alexis; Monsalvo, Maria Laura; Hsu, Hui-Chun; Somaratne, Ransi; Ge, Junbo.
Afiliación
  • Lorenzatti AJ; Instituto Médico DAMIC/Fundación Rusculleda, Córdoba, Argentina.
  • Eliaschewitz FG; Centro de Pesquisas Clínicas, São Paulo, Brazil.
  • Chen Y; Department of Cardiology, Chinese People Liberation Army General Hospital, Beijing, China.
  • Fialkow J; Cardiovascular Center of South Florida, Miami, Florida, USA.
  • Lu J; Department of Endocrinology, Chinese People Liberation Army General Hospital, Beijing, China.
  • Baass A; Department of Medicine, Royal Victoria Hospital, Québec, Canada.
  • Monsalvo ML; Clinical Development, Amgen Inc., Thousand Oaks, California, USA.
  • Hsu HC; Clinical Development, Amgen Inc., Thousand Oaks, California, USA.
  • Somaratne R; Clinical Development, Amgen Inc., Thousand Oaks, California, USA.
  • Ge J; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Clin Cardiol ; 41(9): 1117-1122, 2018 Sep.
Article en En | MEDLINE | ID: mdl-29962050
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Dislipidemias / Lípidos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cardiol Año: 2018 Tipo del documento: Article País de afiliación: Argentina
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Dislipidemias / Lípidos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cardiol Año: 2018 Tipo del documento: Article País de afiliación: Argentina